D.E. Shaw & Co’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Sell |
|
|||||
|
2025
Q1 | $2.43M | Buy |
|
|||||
|
2024
Q4 | $379K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $195K | Sell |
|
|||||
|
2023
Q4 | $856K | Sell |
|
|||||
|
2023
Q3 | $1.78M | Sell |
|
|||||
|
2023
Q2 | $5.05M | Sell |
|
|||||
|
2023
Q1 | $19.6M | Sell |
|
|||||
|
2022
Q4 | $30.2M | Sell |
|
|||||
|
2022
Q3 | $23.9M | Buy |
|
|||||
|
2022
Q2 | $10M | Buy |
|
|||||
|
2022
Q1 | $8.64M | Buy |
|
|||||
|
2021
Q4 | $3.87M | Buy |
|
|||||
|
2021
Q3 | $2.15M | Sell |
|
|||||
|
2021
Q2 | $2.6M | Buy |
|
|||||
|
2021
Q1 | $693K | Sell |
|
|||||
|
2020
Q4 | $1.19M | Sell |
|
|||||
|
2020
Q3 | $1.35M | Sell |
|
|||||
|
2020
Q2 | $3.32M | Sell |
|
|||||
|
2020
Q1 | $3.21M | Buy |
|
|||||
|
2019
Q4 | $2.27M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $124K | Sell |
|
|||||
|
2018
Q2 | $175K | Sell |
|
|||||
|
2018
Q1 | $260K | Buy |
|
|||||
|
2017
Q4 | $411K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $13K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $23K | Sell |
|
|||||
|
2016
Q1 | $525K | Buy |
|
|||||
|
2015
Q4 | $775K | Buy |
|
|||||
|
2015
Q3 | $417K | Sell |
|
|||||
|
2015
Q2 | $851K | Buy |
|